Logo image of ABTS

ABITS GROUP INC (ABTS) Stock Fundamental Analysis

USA - NASDAQ:ABTS - VGG6S34K1136 - Common Stock

10.1448 USD
+0.1 (+1.04%)
Last: 10/3/2025, 8:20:35 PM
9.9999 USD
-0.14 (-1.43%)
After Hours: 10/3/2025, 8:20:35 PM
Fundamental Rating

2

Taking everything into account, ABTS scores 2 out of 10 in our fundamental rating. ABTS was compared to 281 industry peers in the Software industry. ABTS may be in some trouble as it scores bad on both profitability and health. ABTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ABTS had negative earnings in the past year.
ABTS had a positive operating cash flow in the past year.
ABTS had negative earnings in 4 of the past 5 years.
In multiple years ABTS reported negative operating cash flow during the last 5 years.
ABTS Yearly Net Income VS EBIT VS OCF VS FCFABTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -9.27%, ABTS is not doing good in the industry: 61.57% of the companies in the same industry are doing better.
The Return On Equity of ABTS (-12.47%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -9.27%
ROE -12.47%
ROIC N/A
ROA(3y)-65.96%
ROA(5y)-46.05%
ROE(3y)-70%
ROE(5y)-46.84%
ROIC(3y)N/A
ROIC(5y)N/A
ABTS Yearly ROA, ROE, ROICABTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50K 100K

1.3 Margins

ABTS has a Gross Margin (64.30%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ABTS has declined.
ABTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.84%
ABTS Yearly Profit, Operating, Gross MarginsABTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

1

2. Health

2.1 Basic Checks

ABTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABTS remains at a similar level compared to 1 year ago.
The number of shares outstanding for ABTS has been increased compared to 5 years ago.
ABTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABTS Yearly Shares OutstandingABTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
ABTS Yearly Total Debt VS Total AssetsABTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ABTS has an Altman-Z score of -4.17. This is a bad value and indicates that ABTS is not financially healthy and even has some risk of bankruptcy.
ABTS's Altman-Z score of -4.17 is on the low side compared to the rest of the industry. ABTS is outperformed by 81.85% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABTS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, ABTS perfoms like the industry average, outperforming 43.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -4.17
ROIC/WACCN/A
WACC11.34%
ABTS Yearly LT Debt VS Equity VS FCFABTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

ABTS has a Current Ratio of 0.20. This is a bad value and indicates that ABTS is not financially healthy enough and could expect problems in meeting its short term obligations.
ABTS has a Current ratio of 0.20. This is amonst the worse of the industry: ABTS underperforms 96.09% of its industry peers.
ABTS has a Quick Ratio of 0.20. This is a bad value and indicates that ABTS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ABTS (0.20) is worse than 95.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
ABTS Yearly Current Assets VS Current LiabilitesABTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

ABTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.25%, which is quite impressive.
ABTS shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.69%.
The Revenue has been growing by 78.53% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)86.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2437.29%
Revenue 1Y (TTM)31.69%
Revenue growth 3Y212.79%
Revenue growth 5Y78.53%
Sales Q2Q%8.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABTS Yearly Revenue VS EstimatesABTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABTS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABTS Price Earnings VS Forward Price EarningsABTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ABTS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ABTS is cheaper than 82.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.35
ABTS Per share dataABTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABITS GROUP INC

NASDAQ:ABTS (10/3/2025, 8:20:35 PM)

After market: 9.9999 -0.14 (-1.43%)

10.1448

+0.1 (+1.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.17%
Inst Owner ChangeN/A
Ins Owners11.94%
Ins Owner ChangeN/A
Market Cap24.04M
AnalystsN/A
Price TargetN/A
Short Float %2.6%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.42
P/FCF N/A
P/OCF 13.23
P/B 2.4
P/tB 2.4
EV/EBITDA 17.35
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.61
FCFYN/A
OCF(TTM)0.77
OCFY7.56%
SpS2.97
BVpS4.23
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -12.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.3%
FCFM N/A
ROA(3y)-65.96%
ROA(5y)-46.05%
ROE(3y)-70%
ROE(5y)-46.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.84%
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 1.91
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 131.92%
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z -4.17
F-Score6
WACC11.34%
ROIC/WACCN/A
Cap/Depr(3y)268.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)6827.89%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2437.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.69%
Revenue growth 3Y212.79%
Revenue growth 5Y78.53%
Sales Q2Q%8.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.53%
OCF growth 3YN/A
OCF growth 5YN/A